MR-Guided Cryoablation of Prostate Bed Recurrences
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT01727284
- Status
- Enrolling By Invitation
Conditions
- Prostate Tumors
Eligibility Criteria
- Sex
- MALE
- Age
- 30 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- MR-guided cryoablation — PROCEDURE
Study Details
The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
Key Dates
- First listed
- Nov 15, 2012
- Start date
- Dec 12, 2012
- Status verified
- Sep 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: MR-guided cryoablation (freezing of tissue and/or tumors)Patients undergo cryoablation using the Galil MR-compatible cryoablation system and MRI while on study.
Primary Outcome Measure
Evaluation of target lesion at 3-6, 12, 18, 24, and 36 month imaging follow-up [ Time Frame: 3 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | - |
Find similar trials in Rochester, MN
By research site